论文信息 - Second-line FOLFIRI plus ramucirumab with or without prior bevacizumab for patients with metastatic colorectal cancer - 字舞流文

Second-line FOLFIRI plus ramucirumab with or without prior bevacizumab for patients with metastatic colorectal cancer

D. Takahari | H. Osumi | T. Ichimura | K. Yamaguchi | T. Wakatsuki | E. Shinozaki | M. Ogura | M. Suenaga | Y. Ota | A. Ooki | I. Nakayama | Takeshi Suzuki | K. Chin